Free Trial
OTCMKTS:TSNDF

TerrAscend 3/6/2025 Earnings Report

TerrAscend logo
$0.33 -0.02 (-4.35%)
As of 06/3/2025 03:59 PM Eastern

TerrAscend EPS Results

Actual EPS
$0.01
Consensus EPS
-$0.03
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$74.35 million
Expected Revenue
$72.37 million
Beat/Miss
Beat by +$1.98 million
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

The Recession Already Started, Are You Prepared?
Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Americans are shifting savings out of traditional accounts to protect what they’ve earned. If you’re concerned about inflation, rising debt, or a falling dollar, this free Wealth Protection Kit includes three timely reports to help you prepare for what’s coming next.
TerrAscend Closes on Ohio Dispensary Acquisition
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat